MedTrace Logo

Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study

NCT02128178 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 700

Last updated 2015-04-08

No results posted yet for this study

Summary

Obese patients undergoing bariatric surgery warrant VTE prophylaxis because they are at high risk for developing a fatal pulmonary embolism or postthrombotic syndrome. However, a consensus does not exist on the most effective prophylactic approach.

Conditions

Interventions

DRUG

Enoxaparin 40 mg 2 hours before arm

Enoxaparin 40 mg 2 hours before surgery

DRUG

Enoxaparin 40 mg 12 hours before arm

Enoxaparin 40 mg 12 hours before surgery

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • mohamed e abd ellatif, phd · Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-04-30
Completion
2016-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128178 on ClinicalTrials.gov